Works by Poulouin, Yann


Results: 6
    1
    2
    3
    4

    Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Tria.

    Published in:
    Journal of the American Heart Association, 2023, v. 12, n. 18, p. 1, doi. 10.1161/JAHA.122.029216
    By:
    • Goodman, Shaun G.;
    • Steg, Philippe Gabriel;
    • Poulouin, Yann;
    • Bhatt, Deepak L.;
    • Bittner, Vera A.;
    • Diaz, Rafael;
    • Garon, Genevieve;
    • Harrington, Robert A.;
    • Jukema, J. Wouter;
    • Manvelian, Garen;
    • Stipek, Wanda;
    • Szarek, Michael;
    • White, Harvey D.;
    • Schwartz, Gregory G.
    Publication type:
    Article
    5
    6